32645141|t|The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer's Disease: A Preclinical Study in APP/PS1 Transgenic Mice.
32645141|a|BACKGROUND: Depression is highly related to Alzheimer's disease (AD), yet no effective treatment is available. Phosphodiesterase-4 (PDE4) has been considered a promising target for treatment of AD and depression. Roflumilast, the first PDE4 inhibitor approved for clinical use, improves cognition at doses that do not cause side effects such as emesis. METHODS: Here we examined the effects of roflumilast on behavioral dysfunction and the related mechanisms in APPswe/PS1dE9 transgenic mice, a widely used model of AD. Mice at 10 months of age were examined for memory in the novel object recognition and Morris water-maze tests and depression-like behavior in the tail-suspension test and forced swimming test before killing for neurochemical assays. RESULTS: In the novel object recognition and Morris water-maze, APPswe/PS1dE9 mice showed significant cognitive declines, which were reversed by roflumilast at 5 and 10 mg/kg orally once per day. In the tail-suspension test and forced swimming test, the AD mice showed prolonged immobility time, which was also reversed by roflumilast. In addition, the staining of hematoxylin-eosin and Nissl showed that roflumilast relieved the neuronal cell injuries, while terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labelling analysis indicated that roflumilast ameliorated cell apoptosis in AD mice. Further, roflumilast reversed the decreased ratio of B-cell lymphoma-2/Bcl-2-associated X protein and the increased expression of PDE4B and PDE4D in the cerebral cortex and hippocampus of AD mice. Finally, roflumilast reversed the decreased levels of cyclic AMP (cAMP) and expression of phosphorylated cAMP response element-binding protein and brain derived neurotrophic factor in AD mice. CONCLUSIONS: Together, these results suggest that roflumilast not only improves learning and memory but also attenuates depression-like behavior in AD mice, likely via PDE4B/PDE4D-mediated cAMP/cAMP response element-binding protein/brain derived neurotrophic factor signaling. Roflumilast can be a therapeutic agent for AD, in particular the comorbidity of memory loss and depression.
32645141	34	45	Roflumilast	Chemical	MESH:C424423
32645141	92	103	Memory Loss	Disease	MESH:D008569
32645141	108	118	Depression	Disease	MESH:D003866
32645141	122	141	Alzheimer's Disease	Disease	MESH:D000544
32645141	170	173	PS1	Gene	19164
32645141	185	189	Mice	Species	10090
32645141	203	213	Depression	Disease	MESH:D003866
32645141	235	254	Alzheimer's disease	Disease	MESH:D000544
32645141	256	258	AD	Disease	MESH:D000544
32645141	385	387	AD	Disease	MESH:D000544
32645141	392	402	depression	Disease	MESH:D003866
32645141	404	415	Roflumilast	Chemical	MESH:C424423
32645141	536	542	emesis	Disease	MESH:D014839
32645141	585	596	roflumilast	Chemical	MESH:C424423
32645141	600	622	behavioral dysfunction	Disease	MESH:D001523
32645141	678	682	mice	Species	10090
32645141	707	709	AD	Disease	MESH:D000544
32645141	711	715	Mice	Species	10090
32645141	825	835	depression	Disease	MESH:D003866
32645141	1022	1026	mice	Species	10090
32645141	1046	1064	cognitive declines	Disease	MESH:D003072
32645141	1089	1100	roflumilast	Chemical	MESH:C424423
32645141	1198	1200	AD	Disease	MESH:D000544
32645141	1201	1205	mice	Species	10090
32645141	1267	1278	roflumilast	Chemical	MESH:C424423
32645141	1349	1360	roflumilast	Chemical	MESH:C424423
32645141	1374	1396	neuronal cell injuries	Disease	MESH:D002280
32645141	1404	1441	terminal deoxynucleotidyl transferase	Gene	21673
32645141	1451	1455	dUTP	Chemical	MESH:C027078
32645141	1456	1462	biotin	Chemical	MESH:D001710
32645141	1506	1517	roflumilast	Chemical	MESH:C424423
32645141	1548	1550	AD	Disease	MESH:D000544
32645141	1551	1555	mice	Species	10090
32645141	1566	1577	roflumilast	Chemical	MESH:C424423
32645141	1628	1654	Bcl-2-associated X protein	Gene	12028
32645141	1687	1692	PDE4B	Gene	18578
32645141	1697	1702	PDE4D	Gene	238871
32645141	1745	1747	AD	Disease	MESH:D000544
32645141	1748	1752	mice	Species	10090
32645141	1763	1774	roflumilast	Chemical	MESH:C424423
32645141	1808	1818	cyclic AMP	Chemical	MESH:D000242
32645141	1820	1824	cAMP	Chemical	MESH:D000242
32645141	1901	1934	brain derived neurotrophic factor	Gene	12064
32645141	1938	1940	AD	Disease	MESH:D000544
32645141	1941	1945	mice	Species	10090
32645141	1997	2008	roflumilast	Chemical	MESH:C424423
32645141	2067	2077	depression	Disease	MESH:D003866
32645141	2095	2097	AD	Disease	MESH:D000544
32645141	2098	2102	mice	Species	10090
32645141	2115	2120	PDE4B	Gene	18578
32645141	2121	2126	PDE4D	Gene	238871
32645141	2136	2140	cAMP	Chemical	MESH:D000242
32645141	2179	2212	brain derived neurotrophic factor	Gene	12064
32645141	2224	2235	Roflumilast	Chemical	MESH:C424423
32645141	2267	2269	AD	Disease	MESH:D000544
32645141	2304	2315	memory loss	Disease	MESH:D008569
32645141	2320	2330	depression	Disease	MESH:D003866
32645141	Negative_Correlation	MESH:C424423	MESH:D001523
32645141	Positive_Correlation	MESH:C424423	12028
32645141	Negative_Correlation	MESH:C424423	MESH:D000242
32645141	Negative_Correlation	MESH:C424423	MESH:D008569
32645141	Positive_Correlation	MESH:C424423	238871
32645141	Negative_Correlation	MESH:C424423	MESH:D002280
32645141	Negative_Correlation	MESH:C424423	MESH:D003866
32645141	Association	MESH:D001710	21673
32645141	Association	MESH:C027078	21673
32645141	Negative_Correlation	MESH:C424423	MESH:D000544
32645141	Negative_Correlation	MESH:C424423	MESH:D014839
32645141	Association	12064	18578
32645141	Negative_Correlation	MESH:C424423	12064
32645141	Association	MESH:D000242	238871
32645141	Association	MESH:D000544	18578
32645141	Positive_Correlation	MESH:C424423	18578
32645141	Association	MESH:D000544	238871
32645141	Association	MESH:D000242	18578
32645141	Association	12064	238871
32645141	Negative_Correlation	MESH:C424423	MESH:D003072

